Page 12 - pest-POSTEN nr 1, 2003

-pest-POSTEN Side 12

Litteratur 11 Boman J, Hammerschlag MR. Chlamydia
pneumoniae and atherosclerosis: critical assess-
1 Nieto FJ. Infections and atherosclerosis: new ment of diagnostic methods and relevance to
clues from an old hypothesis? Am J Epidemiol 1998; treatment studies. Clin Microbiol Rev 2002; 15: 1-
148: 937-48.
20.
2 Saikku P, Leinonen M, Mattila K, Ekman MR, 12 Speir E, Modali R, Huang ES, Leon MB, Shawl
Nieminen MS, Mäkelä PH et al. Serological F, Finkel T et al. Potential role of human
evidence of an association of a novel Chlamydia, cytomegalovirus and p53 interaction in coronary
TWAR, with chronic coronary heart disease and restenosis. Science 1994; 265: 391-4.
acute myocardial infarction. Lancet 1988; 2: 983-6.
13 Danesh J, Peto R. Risk factors for coronary
3 Shor A, Kuo CC, Patton DL. Detection of heart disease and infection with Helicobacter
Chlamydia pneumoniae in coronary arterial fatty pylori: meta-analysis of 18 studies. BMJ 1998; 316:
streaks and atheromatous plaques. S Afr Med J 1130-2.
1992; 82: 158-61.
14 Kolltveit KM, Eriksen HM. Is the observed
4 Campbell LA, Kuo CC, Grayston JT. Chlamydia association between periodontitis and athero-
pneumoniae and cardiovascular disease. Emerg sclerosis causal? Eur J Oral Sci 2001; 109: 2-7.
Infect Dis 1998; 4: 571-9.
15 Hujoel PP. Does chronic periodontitis cause
5 Gupta S, Leatham EW, Carrington D, Mendall coronary heart disease? A review of the literature.
MA, Kaski JC, Camm AJ. Elevated Chlamydia J Am Dent Assoc 2002; 133 Suppl: 31S-36S.
pneumoniae antibodies, cardiovascular events, and
azithromycin in male survivors of myocardial 16 Ridker PM, Cushman M, Stampfer MJ, Tracy
infarction. Circulation 1997; 96: 404-7. RP, Hennekens CH. Inflammation, aspirin, and the
risk of cardiovascular disease in apparently healthy
6 Gurfinkel E, Bozovich G, Daroca A, Beck E, men. N Engl J Med 1997; 336: 973-9.
Mautner B. Randomised trial of roxithromycin in
non-Q-wave coronary syndromes: ROXIS Pilot 17 Ross R. Atherosclerosis - an inflammatory
Study. ROXIS Study Group. Lancet 1997; 350: 404- disease. N Engl J Med 1999; 340: 115-26.
7 Ånestad G, Scheel O, Hungnes O. Chronic 18 Roberts WC. The underused miracle drugs: the
infections and coronary heart disease. Lancet 1997; statin drugs are to atherosclerosis what penicillin
350: 1028. was to infectious disease. Am J Cardiol 1996; 78:
377-8
8 Lindholt JS, Østergaard L, Henneberg EW, Fas-
ting H, Andersen P. Failure to demonstrate 19 Sparrow CP, Burton CA, Hernandez M, Mundt
Chlamydia pneumoniae in symptomatic abdominal S, Hassing H, Patel S et al. Simvastatin has anti-
aortic aneurysms by a nested polymerase chain inflammatory and antiatherosclerotic activities in-
reaction. Eur J Endovasc Surg 1998; 15: 161-4. dependent of plasma cholesterol lowering.
Arterioscler Thromb Vasc Biol 2001; 21: 115-21.
9 Vainio K, Vengen Ø, Hoel T, Fremstad H, Ånestad
G. Failure to detect Chlamydia pneumoniae in aortic 20 Liappis AP, Kan VL, Rochester CG, Simon GL.
valves and peripheral blood mononuclear cells from The effect of statins on mortality in patients with
patients undergoing aortic valve replacement in bacteremia. Clin Infect Dis 2001; 33: 1352-7.
Norway. Scand J Infect Dis 2002; 34: 660-3. 21 Weinberg ED. Iron loading and disease
10 Apfalter P, Assadian O, Blasi F, Boman J, Gaydos surveillance. Emerg Infect Dis 1999; 5: 346-52.
CA, Kundi M et al. Reliability of nested PCR for 22 Ånestad G, Hoel T, Scheel O, Vainio K.
detection of Chlamydia pneumoniae DNA in Atherosclerosis and tuberculosis: are they both
atheromas: results from a multicenter study chronic infectious diseases? Scand J Infect Dis
applying standardized protocols. J Clin Microbiol 2001; 33: 797.
2002; 40: 4428-34.